Mammalian Ste20-like kinase-1 (MST1) kinase mediates H 2 O 2 -induced cell death by anticancer drugs such as cisplatin in a p53-dependent manner. However, the mechanism underlying MST1 activation by H 2 O 2 remains unknown. Here we show that peroxiredoxin-I (PRX-I) is an essential intermediate in H 2 O 2 -induced MST1 activation and cisplatin-induced cell death through p53. Cell stimulation with H 2 O 2 resulted in PRX-I oxidation to form homo-oligomers and interaction with MST1, leading to MST1 autophosphorylation and augmentation of kinase activity. In addition, RNA interference knockdown experiments indicated that endogenous PRX-I is required for H 2 O 2 -induced MST1 activation. Live-cell imaging showed H 2 O 2 generation by cisplatin treatment, which likewise caused PRX-I oligomer formation, MST1 activation and cell death. Cisplatin-induced PRX-I oligomer formation was not observed in embryonic fibroblasts obtained from p53-knockout mice, confirming the importance of p53. Indeed, ectopic expression of p53 induced PRX-I oligomer formation and cell death, both of which were cancelled by the antioxidant NAC. Moreover, we succeeded in reconstituting H 2 O 2 -induced MST1 activation in vitro, using purified PRX-I and MST1 proteins. Collectively, our results show a novel PRX-I function to cause cell death in response to high levels of oxidative stress by activating MST1, which underlies the p53-dependent cytotoxicity caused by anticancer agents.
Introduction
Oxidative stress greatly affects diverse biological phenomena, including cell death, aging and various disorders ranging from cancers to neurodegenerative diseases (Finkel and Holbrook, 2000) . However, the molecular mechanisms by which oxidative stress is relayed inside cells remain poorly characterized. Protein kinases generally have key roles in signal transduction driven by various stimuli (Karin and Hunter, 1995) . For example, mammalian Ste20-like kinase-1 (MST1) is a Ser/Thr kinase that is activated by apoptosis-inducing stimuli (de Souza and Lindsay, 2004) . Lehtinen et al. (2006) reported that MST1 is activated by H 2 O 2 and induces cell death by phosphorylating the transcription factor FOXO in primary mammalian neurons. Furthermore, Ste20 mediates H 2 O 2 -induced cell death by phosphorylating histone H2B in Saccharomyces cerevisiae (Ahn et al., 2005) . These studies implicate MST1 as a crucial kinase in H 2 O 2 -induced cell death, but MST1 activation mechanisms by H 2 O 2 have yet to be clarified.
MST1 is also known as a tumor-suppressor protein involved in the death of cancer cells treated with anticancer drugs such as cisplatin, a platinum-based DNA-damaging agent (O'Neill et al., 2005; Ren et al., 2008) . It is widely accepted that p53 is a key determinant for cell death in response to anticancer drugs (Lowe et al., 1993 (Lowe et al., , 1994 . By using Drosophila genetics, Colombani et al. (2006) discovered that Dmp53 (Drosophila melanogaster p53) activates Hippo, the Drosophila MST1 homolog, to induce cell death responses elicited by DNA-damaging ionizing radiation, suggesting a functional link between p53 and MST1. Moreover, it has been reported that p53-dependent apoptosis occurs through increasing oxidative stress (Johnson et al., 1996; Polyak et al., 1997; Li et al., 1999) . Indeed, expression of p53 induces the generation of mitochondrial reactive oxygen species (ROS), likely causing MST1 activation. However, the precise mechanisms of p53-induced cell death through oxidative stress remain unknown.
Recent studies have uncovered a role for H 2 O 2 as a signaling molecule under various physiological/pathological settings (Rhee, 2006; Veal et al., 2007) . Several studies have found many H 2 O 2 -responsive proteins, among which peroxiredeoxins (PRXs) are the most extensively characterized (Rhee et al., 2005) . The main function of PRXs generally has been thought to be H 2 O 2 removal by catalysis of H 2 O 2 reduction to H 2 O. However, Jang et al. (2004) reported quite unexpectedly that high levels of H 2 O 2 stimulate PRX-I and PRX-II to form homo-oligomers with chaperone-like activities. In addition, Tpx1, the yeast PRX-I homolog, mediates H 2 O 2 -induced activation of the p38/JNK homolog Sty1, by forming a transient, intermolecular disulfide bond (Veal et al., 2004) . Therefore, PRX-I is now regarded not only as a scavenger of H 2 O 2 , but also as an important intermediate activating H 2 O 2 -responsive signaling pathways.
Here, we investigated the possible involvement of PRX-I in H 2 O 2 -and cisplatin-induced MST1 activation and cell death. In response to H 2 O 2 , PRX-I formed oligomers that specifically associated with MST1. Overexpression and knockdown analyses indicated an essential role of PRX-I in MST1 activation by H 2 O 2 in cells. Live-cell imaging analyses clearly showed that cisplatin treatment induced massive H 2 O 2 generation also resulting in PRX-I oligomer formation. This occurred in a p53-dependent manner because primary murine embryonic fibroblasts (MEFs) obtained from p53 À/À mice did not form PRX-I oligomers. Moreover, p53 À/À MEFs and PRX-I-knockdown cancer cells were unable to activate MST1 in response to cisplatin and resisted cell death. Further, we successfully reconstituted MST1 activation by H 2 O 2 and PRX-I in vitro, using purified recombinant proteins.
Results
Specific association of MST1 with oligomeric PRX-I H 2 O 2 induces both MST1 activation and PRX-I oligomerization, prompting us to speculate that MST1 may be activated by associating with oligomeric PRX-I. We first checked whether PRX-I forms oligomers as reported previously. We ectopically expressed PRX-I (wild-type (WT) and three different Cys mutants, C51S, C173S and C83S) in COS-7 cells, which were subsequently stimulated with H 2 O 2 . Cys51 and Cys173, both of which are known to function as the catalytic center for the peroxidase activity, have an important but opposite role in oligomer formation (Jang et al., 2004; Moon et al., 2005; Rhee et al., 2005) . Yeast C47S (C51S in mammals) PRX-I does not form oligomers at all even in the presence of H 2 O 2 , and yeast C170S (C173S in mammals) PRX-I constitutively forms oligomers even in the absence of H 2 O 2 (Jang et al., 2004) . Cys83 is also important for oligomerization because C83S PRX-I barely forms oligomers in comparison with WT PRX-I (Lee et al., 2007) . Cells were then harvested and cell lysates were subjected to native PAGE without sodium dodecyl sulfate (SDS) or reducing agents. As shown in Figure 1a , a ladder-like signal of WT PRX-I appeared above the main band when cells were treated with H 2 O 2 . 2-Cys PRXs, including PRX-I, is known to form obligate homodimers (Wood et al., 2003) . The main band and the ladder bands should correspond to the dimer and oligomer forms of PRX-I, respectively, because a very similar pattern was reported previously in the case of plant 2-Cys PRX (Ko¨nig et al., 2002) . By contrast, C173S PRX-I constitutively formed oligomers but C51S or C83S PRX-I did not form oligomers even in the presence of H 2 O 2 . These results agree with previous studies (Jang et al., 2004; Moon et al., 2005; Lee et al., 2007) . We also performed immunoblot analyses using an anti-PRX-SO 2 /SO 3 antibody and found that the hyperoxidation status of WT PRX-I correlated well with oligomer formation. However, we did not observe so clear positive signals in the case of C173S PRX-I, and thus hyper-oxidation of PRX-I may not be required for oligomer formation.
Having confirmed PRX-I oligomerization, we examined possible PRX-I interaction with MST1. PRX-I (WT and the Cys mutants) and MST1 were coexpressed and cell lysates were subjected to co-immunoprecipitation. The results clearly indicated that MST1 associates with WT PRX-I depending on H 2 O 2 stimulation. However, MST1 associated constitutively with C173S PRX-I (Figure 1b ), correlating well with the oligomeric status of PRX-I (Figure 1a ). There are six different genes encoding PRX isoforms in mammalian genomes; PRX-II is also reported to form oligomers (Jang et al., 2004; Moon et al., 2005) . Therefore, we also examined whether MST1 associates with PRX-II, but observed no positive signal (Figure 1c ), indicating that MST1 interacted specifically with PRX-I. In support of this result, PRX-II barely formed oligomers compared with PRX-I (Supplementary Figure 1) .
We then performed co-immunoprecipitation analyses against endogenous MST1/2 and PRX-I proteins in U2OS cells, and confirmed that they form complexes in vivo when cells are treated with H 2 O 2 (Figure 1d ). To examine the direct interaction between these proteins, we expressed and purified GST-MST1 and PRX-I recombinant proteins. The purified proteins were incubated in the presence of H 2 O 2 or the reducing agent dithiothreitol (DTT) and then subjected to a pull-down assay using glutathione beads. The results indicated a clear positive signal in the presence of H 2 O 2 (Figure 1e ), indicating their direct interaction. We also confirmed that recombinant PRX-I formed oligomers in vitro similar to those in cells.
PRX-I mediates H 2 O 2 -induced MST1 activation As H 2 O 2 stimulation is known to activate MST1, we next investigated the possible importance of PRX-I in MST1 activation. First, we coexpressed MST1 with PRX-I (WT and the Cys mutants) in COS-7 cells and examined MST1 autophosphorylation, which reflects MST1 activation (Praskova et al., 2004) . As shown in Figure 2a , expression of WT PRX-I significantly augmented MST1 autophosphorylation. In addition, C173S PRX-I, which constitutively associates with MST1 (Figure 1b) , strongly induced MST1 autophosphorylation even without H 2 O 2 stimulation. We also examined the effect of PRX-II and found that it did not stimulate MST1 autophosphorylation (Supplementary Figure 2) . Therefore, there was a very clear correlation between MST1 autophosphorylartion and interaction with oligomeric PRX-I. c-Jun N-terminal kinase-1 (JNK1) is also known to be activated by H 2 O 2 and has a crucial role in H 2 O 2 -induced signaling (Guyton et al., 1996) . Therefore, we examined the possible effect of PRX-I expression on JNK1 activity. In contrast to the case of MST1, we did not observe any stimulatory effect of PRX-I, although H 2 O 2 -induced activation of JNK1 was clearly observed (Supplementary Figure 3) .
As mentioned above, MST1 autophosphorylation is a useful marker for estimating MST1 activation, but whether MST1 kinase activity was actually promoted was still unknown. Therefore, we aimed to measure MST1 kinase activity directly by collecting MST1 protein by immunoprecipitation and performing kinase assays in vitro. First, we used myelin basic protein as substrate for assaying MST1 kinase activity, but found only a weak signal (data not shown). Therefore, we used a GST-fusion MOBKL1B protein, which was reported to be a good MST1 substrate (Praskova et al., 2008) . We basically found similar results to those in the autophosphorylation analyses (Figure 2b ), thus confirming MST1 activation by PRX-I. We also noticed that expression of WT PRX-I could induce statistically significant MST1 activation even in the absence of H 2 O 2 . The results shown in Figure 1 show very weak but significant positive signals of WT PRX-I oligomer formation ( Figure 1a ) and complex formation with MST1 ( Figure 1b ) even in the absence of H 2 O 2 , which presumably resulted in weak activation of MST1. Because MST1 activation has been linked to apoptosis, we next examined the effect of MST1 coexpression with PRX-I on apoptosis as a biological measure for MST1 activation. When MST1 was ectopically expressed alone in U2OS cells, B15% of cells underwent apoptosis showing typical chromatin condensation ( Figure 2c ). A slight but significant increase in the apoptotic rate was observed by coexpression of WT PRX-I, whereas C173S PRX-I further enhanced the apoptotic rate to B35%, which is consistent with the stronger ability of C173S PRX-I to activate MST1 (Figures 2a and b) .
To examine the requirement of endogenous PRX-I for H 2 O 2 -induced activation of endogenous MST1/2, short interfering RNA (siRNA) against PRX-I was introduced into U2OS cells to reduce endogenous PRX-I expression. As shown in Supplementary Figure 4 , treatment with PRX-I siRNA specifically suppressed the expression of PRX-I, without any significant effects on PRX-II expression. Cells were then stimulated with Proteins were subjected to SDS-PAGE and Coomassie Brilliant Blue (CBB) staining. The immunoblot of recombinant PRX-I subjected to native PAGE is also shown (left). DTT, dithiothreitol; IAA, iodoacetamide; GST, glutathione-S-transferase; MST1, mammalian Ste20-like kinase-1; PRX-I, peroxiredoxin-I; SDS-PAGE, sodium dodecyl sulfate-PAGE.
PRX-I mediates H 2 O 2 -induced activation of MST1
A Morinaka et al H 2 O 2 and MST1/2 autophosphorylation was examined by immunoblotting. As shown in Figure 2d , H 2 O 2 stimulation resulted in significant activation of endogenous MST1/2 in control cells, but it was clearly suppressed in PRX-I-knockdown cells. Collectively, these results indicate that PRX-I is an essential intermediate linking H 2 O 2 stimulation to MST1 activation.
Cisplatin induces PRX-I oligomer formation through p53
It has been reported that MST1 is important for anticancer drugs to induce cell death (Ren et al., 2008) , prompting us to examine the possible roles of H 2 O 2 and PRX-I in this process. First, we confirmed the requirement of MST1/2 for cisplatin-induced apoptosis in U2OS cells (Supplementary Figure 5) . We then performed H 2 O 2 -imaging analysis using GFP-HyPer, which specifically responds to H 2 O 2 by increasing its fluorescent signal intensity (Belousov et al., 2006) . As shown in Figure 3a , treatment of COS-7 cells with cisplatin gradually increased the GFP-HyPer signal, which was evident after 4 h. By contrast, we did not observe any significant increase in GFP-HyPer-expressing cells not treated with cisplatin or control GFPexpressing cells treated with cisplatin. Having confirmed H 2 O 2 generation, we next examined PRX-I oligomer formation and found that cisplatin treatment could induce oligomers of both ectopically expressed PRX-I in COS-7 cells and endogenous PRX-I in U2OS cells (Figures 3b and c) . We noticed that p53 levels significantly increased in U2OS cells upon cisplatin treatment (Figure 3c ) as reported previously (Praskova et al., 2008) . Therefore, we next examined whether p53 has any important role in PRX-I oligomer formation induced by cisplatin treatment. As shown in Figure 3d , p53 ectopic expression by itself could induce PRX-I oligomerization, which was abrogated by treatment with the antioxidant N-acetyl cysteine (NAC). We also examined the apoptotic rate of the cells and found that p53 expression raised the number of apoptotic cells with condensed chromatin (from 4.3% in control cells to 22.6% in p53-expressing cells; Figure 3e ). This cell death was again inhibited by NAC treatment, and thus, PRX-I oligomer formation correlated well with p53 apoptosis-inducing ability, suggesting a functional link between p53 and PRX-I.
To indicate a definite endogenous p53 requirement for cisplatin-induced H 2 O 2 generation and PRX-I oligomerization, we isolated MEFs from WT (p53 þ / þ ) or p53- with an anti-FLAG antibody and subjected to in vitro kinase assays using [g-32 P]ATP and recombinant MOBKL1B as substrate. The phosphorylation level of MOBKL1B was analyzed by autoradiography and the relative radioactivity is indicated. The data are the mean ± s.e.m. for n ¼ 3. *Po0.05, **Po0.01 indicates significant difference by one-way analysis of variance (P ¼ 0.0001) followed by Dunnett's multiple comparison test. (c) U2OS cells were transfected with the indicated constructs together with GFP-expressing plasmids. The cells were fixed and DAPI-stained to visualize chromatin condensation. GFP-positive cells were examined for apoptosis. The data are the mean±s.e.m. for n ¼ 3. For each experiment, more than 100 cells were examined. *Po0.05 indicates significant difference by one-way analysis of variance (P ¼ 0.004) followed by Dunnett's multiple comparison test among the Myc-MST1-transfected groups. (d) U2OS cells were transfected with PRX-I siRNA and treated with 100 mM H 2 O 2 for 30 min. Cell lysates were analyzed using the indicated primary antibodies. DAPI, 4 0 ,6-diamidino-2-phenylindole; GFP, green fluorescent protein; MST1, mammalian Ste20-like kinase-1; PRX-I, peroxiredoxin-I; siRNA, short interfering RNA. Figure 6 and Figure 3f ). This PRX-I oligomer formation was abrogated by NAC treatment (Supplementary Figure 7) . We further investigated possible relationships
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A Morinaka et al with human cancers, which often lack functional p53, by performing similar experiments using human cancerderived cell lines such as U2OS (osteosarcoma, p53-positive), SaOS-2 (osteosarcoma, p53-negative), MCF-7 (breast cancer, p53-positive) and MDA-MB-231 (breast cancer, p53-mutated). As shown in Figure 3g , we could confirm that cisplatin-induced PRX-I oligomer formation occurred in U2OS and MCF-7 cells but not in SaOS-2 and MDA-MB-231 cells, which is consistent with the functional status of p53.
PRX-I mediates cisplatin-induced MST1 activation and cell death It has been reported that cisplatin treatment induces MST1 activation (Ren et al., 2008) . The results shown in Figure 3 clearly show that cisplatin induces PRX-I oligomer formation through p53. Therefore, we speculated that PRX-I may mediate cisplatin-induced MST1 activation. To test this hypothesis, we first examined the complex formation status by ectopically expressing MST1 and PRX-I in COS-7 cells, and confirmed that cisplatin treatment significantly augmented the coimmunoprecipitation of the two proteins ( Figure 4a ). We next examined complex formation between endogenous MST1 and PRX-I in U2OS cells. When cells were not treated with cisplatin, only very weak coimmunoprecipitation signal was observed, but cisplatin treatment significantly increased this signal (Figure 4b ). To directly examine the importance of PRX-I in cisplatin-induced MST1 activation, we next performed PRX-I-knockdown analysis and found that MST1 activation was severely impaired in cells treated with PRX-I siRNA (Figure 4c ). We also examined the PRX-I-knockdown effect on the apoptotic rate. We observed a slight increase in the apoptotic rate by PRX-I knockdown itself (from 4.7% in control cells to 12.3% in PRX-I-knockdown cells; Figure 4d ). As PRX-I has an important role in scavenging H 2 O 2 , this increase is probably caused by augmented oxidative stress. Cisplatin treatment induced a significant increase in the apoptotic rate in control cells. However, PRX-I-knockdown cells relatively resisted against cisplatin and their apoptotic rate was significantly lower than in control cells, thus uncovering an unexpected role for PRX-I in cell-death responses induced by cisplatin treatment. We also examined the importance of p53 in cisplatininduced MST1 activation. MEFs obtained from p53
À/À mice were treated with cisplatin and subsequently, levels of phosphorylated endogenous MST1/2 were examined by immunoblotting. As shown in Figure 4e , cisplatin-induced phosphorylation of MST1/ 2 was very weak in p53 À/À MEFs, which is consistent with the p53-dependent PRX-I oligomer formation (Figure 3f) . We also performed similar experiments by using human cancer cells and confirmed that p53-positive U2OS and MCF-7 cells activated MST1/2 in response to cisplatin, but SaOS-2 (p53-negative) and MDA-MB-231 (p53-mutated) cells did not (Figure 4f ).
Mechanism of MST1 activation by PRX-I and H 2 O 2
Finally, we tried to clarify the molecular mechanisms of MST1 activation by PRX-I and H 2 O 2 . For this purpose, we purified various preparations of recombinant MST1 and PRX-I proteins (Figure 5a ). We first incubated fulllength MST1 with or without PRX-I under a reducing (10 mM DTT) or oxidizing (10 mM H 2 O 2 ) condition, and then examined MST1 autophosphorylation. As shown in Figure 5b , the levels of phosphorylated MST1 specifically increased when PRX-I was with H 2 O 2 . Moreover, the results of kinase assays using MOBKL1B as substrate also confirmed MST1 activation by PRX-I and H 2 O 2 (Supplementary Figure 8) . Therefore, we successfully reconstituted H 2 O 2 -induced MST1 activation by PRX-I, indicating a crucial role for PRX-I in MST1 activation.
We then further explored molecular mechanisms underlying this activation. The NH 2 -terminal half of MST1 contains a kinase domain with the autophosphorylation site and the COOH-terminus includes an inhibitory domain for the kinase activity (Figure 5a ) (Creasy et al., 1996; Praskova et al., 2004) . Thus, we created two glutathione-S-transferase (GST)-fusion MST1 fragments, lacking either the NH 2 -or the COOH-terminal region (GST-MST1 C or GST-MST1 N, respectively) (Figure 5a ), and examined their binding ability to recombinant PRX-I by pull-down assays. As shown in Figure 5c , GST-MST1 C, but not GST-MST1 N, could specifically precipitate PRX-I in the presence Figure 3 Cisplatin induces oligomer formation of PRX-I through p53. (a) COS-7 cells were transfected with GFP-HyPer-expressing plasmids and then treated with 25 mM cisplatin for the indicated durations. The relative intensity of the GFP fluorescence in cells was analyzed. The data are the mean ± s.e.m. for n ¼ 3. For each experiment, more than 50 cells were examined. *Po0.05, **Po0.01 (against the 'HyPer' group) and w Po0.05 (against the 'GFP þ Cisplatin' group) indicate significant difference by one-way analysis of variance (Po0.05) followed by Bonferroni's multiple comparison test. (b) COS-7 cells transfected with the indicated constructs were treated with cisplatin for the indicated durations. Cell lysates were treated with IAA and immunoblotted under native or denaturing conditions. (c) U2OS cells were treated with cisplatin for the indicated durations. Cell lysates were treated with IAA and immunoblotted under native or denaturing conditions. (d) U2OS cells were transfected with the indicated constructs and treated with NAC. Cell lysates were treated with IAA and immunoblotted under native or denaturing conditions. (e) U2OS cells were transfected with the indicated constructs together with GFP-expressing plasmids and treated with NAC. The cells were fixed and DAPI-stained to visualize chromatin condensation. GFP-positive cells were examined for apoptosis. The data are the mean ± s.e.m. for n ¼ 3. For each experiment, more than 100 cells were examined. **Po0.01 indicates significant difference by one-way analysis of variance (P ¼ 0.0009) followed by Bonferroni's multiple comparison test. (f) MEFs from p53 þ / þ or p53 À/À mice were treated with cisplatin. Cell lysates were treated with IAA and immunoblotted under native or denaturing conditions. (g) Human cancer-derived cell lines such as U2OS, SaOS-2, MCF-7 and MDA-MB-231 were treated with cisplatin. Cell lysates were treated with IAA and immunoblotted under native or denaturing conditions. DAPI, 4
0 ,6-diamidino-2-phenylindole; GFP, green fluorescent protein; IAA, iodoacetamide; MEF, murine embryonic fibroblast; NAC, N-acteyl cysteine; PRX-I, peroxiredoxin-I. of H 2 O 2 . As MST1 N has been shown to possess increased kinase activity compared with full-length MST1 in similar kinase assays in vitro (Creasy et al., 1996) , we assumed that the direct interaction of the COOH-terminal region with the NH 2 -terminal kinase domain inhibits the kinase activity and that H 2 O 2 -induced association with PRX-I abrogates this interaction, resulting in the opening of the kinase domain. Indeed, interaction of recombinant MST1 C with GST-MST1 N was confirmed (Figure 5d ). Furthermore, this interaction was significantly weakened by addition of PRX-I with H 2 O 2 but not with DTT.
We next assessed the effect of PRX-I oligomers on the kinase activity of MST1. Purified MST1 N showed an autophosphorylation signal and addition of MST1 C suppressed it (Figure 5e ), thus supporting the autoinhibitory regulation of the MST1 kinase activity. We then added PRX-I to the mixture of MST1 N and MST1 C, and found that PRX-I could clearly negate the suppression imposed by MST1 C when incubation was under an H 2 O 2 -driven oxidative condition. Based on these results, we concluded that oligomeric PRX-I activates MST1 by dissociating the inhibitory COOHterminal region of MST1 from the NH 2 -terminal kinase domain, thus mediating the H 2 O 2 -induced MST1 activation.
Discussion
Here we showed a quite unexpected MST1 activation mechanism by H 2 O 2 , mediated by oligomeric PRX-I. We elucidated novel PRX-I functions in signal transduction promoting appropriate responses to oxidative stress. We also showed the important role of PRX-I in the p53-dependent cell death triggered by the anticancer drug cisplatin. Recent studies have suggested a potential approach to treat cancers by manipulating their redox environment. In these studies, it has been indicated that cancer cells are very sensitive to artificial ROS elevation because most cancer cells are chronically subjected to oxidative stress and an additional increase in ROS levels brings the level of oxidative stress to a fatal degree (reviewed by Trachootham et al., 2009) . For example, b-phenylethyl isothiocyanate, a natural compound that promotes ROS generation, is reported to induce apoptosis selectively in cancer cells (Trachootham et al., 2006) . Although cell death was attributed to aberrant regulation of H-Ras, JNK and nuclear factor-kB, PRX-Imediated MST1 activation probably also takes part in this process, and further examinations of these pathways could facilitate the development of better chemotherapeutic agents. Recent studies have indicated the importance of a mammalian signaling pathway equivalent to the Drosophila Hippo pathway in tumor suppression (Harvey and Tapon, 2007; Zeng and Hong, 2008) . In Drosophila, Hippo activates Warts (LATS1/2 in mammals) together with Salvador (WW45 in mammals). Activated Warts then excludes an oncogenic transcription factor Yorkie (YAP in mammals) from the nucleus and induces apoptosis. The Hippo pathway appears to be conserved in mammals, and the human genes for several pathway components have been found to be mutated in cancers (O'Neill et al., 2005; Harvey and Tapon, 2007; Zeng and Hong, 2008) . PRX-I is also suggested to suppress cancer development because mice lacking the PRX-I gene have a short life span owing to frequent development of several cancers (Neumann et al., 2003; Egler et al., 2005; Graves et al., 2009) . In these reports, oncogenesis has been attributed to loss of PRX-I peroxidase activity. In vitro kinase assays were performed by mixing the indicated recombinant proteins in the presence of 10 mM DTT or 10 mM H 2 O 2 . Proteins were analyzed using the indicated primary antibodies. (c) GST-MST1 pull-down assays for PRX-I. Proteins were subjected to SDS-PAGE and CBB staining. (d) GST-MST1 pull-down assays for MST1 C in the presence of PRX-I. Proteins were subjected to SDS-PAGE and CBB staining. (e) In vitro kinase assays were performed using the indicated recombinant proteins in the presence of 10 mM H 2 O 2 or 10 mM DTT. Proteins were analyzed using the indicated primary antibodies or by CBB staining. DTT, dithiothreitol; GST, glutathione-S-transferase; MST1, mammalian Ste20-like kinase-1; PRX-I, peroxiredoxin-I; SDS-PAGE, sodium dodecyl sulfate-PAGE.
However, mice lacking the PRX-II gene, the closest homolog of PRX-I, do not show cancers in any cell type or tissue (Choi et al., 2005; Lee et al., 2007) . PRX-II is expressed in a wide variety of tissues and has a more potent peroxidase activity than PRX-I (Rhee et al., 2005; Lee et al., 2007) . Indeed, PRX-II À/À mice show a massive increase in cellular ROS levels (Choi et al., 2005) . Therefore, loss of peroxidase activity alone does not account for the cancer-forming phenotype in PRX-I À/À mice. It should be noted that PRX-I, but not PRX-II, is able to bind to and activate MST1 (Figure 1c and Supplementary Figure 2) , which may explain the phenotypic differences between PRX-I À/À and PRX-II À/À mice. PRX-I and PRX-II are highly homologous proteins (91% homology and 78% identity in human) and thus expected to have similar roles intracellularly. However, our study clearly shows a difference in their role related to MST1 (Figure 1c and Supplementary Figure 2) . One possible reason may be in their oligomerization tendency because PRX-I promptly forms oligomers in response to low H 2 O 2 levels, whereas PRX-II is comparatively resistant to H 2 O 2 -induced oligomerization (Lee et al., 2007) . This difference can be attributed to the presence of PRX-I Cys83, which is absent in PRX-II. PRX-I Cys83 reportedly forms a disulfide linkage with another PRX-I Cys83, thus promoting homo-oligomer formation. Consistently, our study also confirmed that C83S PRX-I did not efficiently form oligomers (Figure 1a) , only weakly binding to and activating MST1 (Figures 1b and 2a) .
PRX-I is a well-known antioxidant enzyme thought to protect cells against oxidative stress by reducing H 2 O 2 (Rhee et al., 2005) . Indeed, there are several reports indicating that PRX-I inactivation results in the elevation of ROS levels and oxidative DNA damage (Neumann et al., 2003; Egler et al., 2005; Rhee et al., 2005; Graves et al., 2009) . However, we showed here a quite unexpected PRX-I function, linking ROS to cell death. This difference in PRX-I function apparently depends on the degree of oxidative stress. Indeed, the extent of PRX-I oligomerization depends on the concentration of H 2 O 2 and correlates well with cell death (Supplementary Figure 9 ). PRX-I reduces H 2 O 2 and protects cells from oxidative stress when H 2 O 2 level is within a manageable range. However, when cells are exposed to excessive H 2 O 2 levels, PRX-I is inactivated as a peroxidase and forms oligomers (Jang et al., 2004; Moon et al., 2005) , thus resulting in MST1 activation. In this case, we postulate that PRX-I contributes to protection of the whole organism by removing cells severely damaged by excess ROS, avoiding cancer development.
Materials and methods

Expression constructs
The cDNAs for mouse PRX-I, mouse PRX-II, human MST1, human JNK1 and human MOBKL1B were generated by reverse transcription-PCR. The GFP-HyPer-expressing plasmid was purchased from Evrogen (Moscow, Russia). Site-directed mutagenesis was performed using the Quick-Change Mutagenesis kit (Stratagene, Santa Clara, CA, USA). MST1 lacking the COOH-terminus (MST1 N, 1-308) and NH 2 -terminus (MST1 C, 302-488) were generated by PCR. The cDNA fragments were inserted into pEF-BOS, pCAGGS (Clontech Laboratories, Mountain View, CA, USA), pGEX-2T (Amersham, Piscataway, NJ, USA) and pFastBac1 (Invitrogen, Carlsbad, CA, USA) plasmid vectors. The siRNA duplex oligonucleotides against human PRX-I were purchased from Invitrogen. The control siRNA had the shuffled sequence of the human PRX-I siRNA and was designed as a non-silencing siRNA that does not correspond to any known mammalian mRNA sequence. The target mRNA sequences are as follows: PRX-I,
0 .
Antibodies and reagents
Mouse anti-FLAG (M2) (Sigma, St Louis, MO, USA), rabbit anti-Myc (A-14) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-MST1/2 (Bethyl Laboratories, Montgomery, TX, USA), rabbit anti-PRX-I, rabbit anti-PRX-SO 2 /SO 3 (Abcam, Cambridge, MA, USA), rabbit anti-phospho-MST1/2 (Thr183), rabbit anti-JNK1/2, rabbit anti-phospho-JNK1/2 (Thr183/ Tyr185), mouse anti-p53 (1C12) (Cell Signaling Technology, Beverley, MA, USA, for detection of mouse p53), mouse anti-p53 (Ab-6, for detection of human p53) (Calbiochem, Darmstadt, Germany) and mouse anti-actin (Millipore, Billerica, MA, USA) were used. Cisplatin (Yakult Honsha, Tokyo, Japan) and NAC (Sigma) were from commercial sources.
Recombinant proteins
Recombinant proteins of MST1, PRX-I and MOBKL1B were expressed as GST fusions in Escherichia coli (PRX-I and MOBKL1B) or in Sf9 cells (MST1, MST1 N and MST1 C). They were purified using glutathione-sepharose beads (GE Healthcare, Little Chalfont, UK) and eluted with excess glutathione. The GST tag was removed by incubating GSTfusion proteins bound to the glutathione-sepharose beads with thrombin (GE Healthcare) for PRX-I or with PreScission protease (GE Healthcare) for MOBKL1B, MST1, MST1 N and MST1 C for 4 h at 4 1C. Thrombin was removed by using benzamidine-sepharose beads (Sigma).
Native PAGE Cell lysates in native PAGE sample buffer (50 mM Tris-HCl (pH 6.8), 10% glycerol, 1% deoxycholate and 15 mM iodoacetamide (IAA)) were subjected to native PAGE. The cathode buffer contained 0.2% deoxycholate (Iwamura et al., 2001) .
Cell culture and transfection COS-7, U2OS, SaOS-2 and p53 þ / þ or p53 À/À MEFs were cultured in Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum, and MCF-7 and MDA-MB-231 cells were cultured in RPMI-1640 with 10% fetal bovine serum. SaOS-2 and MCF-7 cells were obtained from the Japanese Collection of Research Bioresources, and MDA-MB-231 cells were from American Type Culture Collection. COS-7 and U2OS cells were generous gifts from Dr Tadaomi Takenawa (Kobe University) and Kiyoko Fukami (Tokyo University of Pharmacy and Life Sciences), respectively. The cancer cells are routinely authenticated through cell morphology monitoring and growth curve analysis, and we confirmed that p53 status agrees with the information on the International Agency for Research on Cancer TP53 database (http://www-p53. iarc.fr/). Primary MEFs were derived from 13.5-day embryos and genotyped by PCR. p53 þ /À mice were purchased from RIKEN BioResource Center (BRC) (Tsukada et al., 1993) . p53 À/À embryos were derived from p53 þ /À crosses maintained on a C57BL/6C background. Cells were seeded in 36-or 60-mm dishes, cultured overnight and transfected with Lipofectamine 2000 (Invitrogen). The cells were harvested with lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100) 1 or 2 days after transfection.
H 2 O 2 -imaging analysis Cells were transfected with a GFP-HyPer-expressing plasmid. The cells were cultured for 24 h and then treated with 25 mM cisplatin or 100 mM H 2 O 2 . The relative intensities of fluorescence emitted from the cells were analyzed by real-time microscopy (the signal intensity just before stimulation was set to be 1.0). We performed time-lapse imaging analyses using an Olympus IX81 microscope equipped with an Olympus DP30BW camera. Fluorescence observation was performed using a conventional filter set for green fluorescent protein (GFP). We quantified image intensities with the DP Controller software (Olympus, Tokyo, Japan) and the ImageJ software (National Institutes of Health, Bethesda, MD, USA). For each experiment, more than 50 cells were examined.
Apoptosis assay
Cells were transfected with various expression plasmids or siRNAs together with GFP-expressing plasmids. The cells were cultured for 24 h and then treated with 25 mM cisplatin for 48 h. The cells were fixed with formaldehyde and then stained with 4 0 ,6-diamidino-2-phenylindole (DAPI) to visualize nuclei. GFP-positive cells were assessed for their chromatin condensation. For each experiment, more than 100 cells were measured.
In vitro kinase assay The kinase reaction was assessed in a kinase buffer (20 mM Tris-HCl (pH 7.5), 15 mM MgCl 2 ) containing either 10 mM DTT or 10 mM H 2 O 2 . Recombinant MOBKL1B was used as the substrate. In the absence of PRX-I or MST1 C, equal amounts of GST were added to adjust the total protein concentration. The kinase reaction was initiated by addition of 1 mCi [g-32 P]ATP and then incubated for 5 min at 30 1C. The reaction was then stopped by adding the SDS sample buffer. The samples were subjected to SDS-PAGE and the radioactivity of MOBKL1B was determined by autoradiography (BAS2000; FUJIFILM Corporation, Tokyo, Japan).
Real-time PCR analyses
Real-time PCR experiments were performed using MiniOpticon (Bio-Rad, Hercules, CA, USA) using the iQ SYBR green Supermix (Bio-Rad). The quality of the final PCR product was checked by agarose gel electrophoresis and it was confirmed that there were no obvious non-specifically amplified DNAs. The primers used are as follows: PRX-I (5 0 -GACCCATGAA CATTCCTTTG-3 0 and 5 0 -AGGCTTGATGGTATCACTGC-3 0 ), PRX-II (5 0 -GTCCGTGCGTCTAGCCTTTG-3 0 and 5 0 -TCCC TTTGTAGTCCGACAGC-3 0 ) and GAPDH (5 0 -AGGTGAA GGTCGGAGTCAACG-3 0 and 5 0 -AGGGGTCATTGATGG CAACA-3 0 ).
Animal experiments
We appropriately treated mice according to the guidelines for proper conduct of animal experiments (issued by the Science Council of Japan), and we received approval of this experiment from Osaka University.
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